Glen Eagle Advisors, LLC Cytokinetics Inc Transaction History

Glen Eagle Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $5,982 - $9,381	-125 Closed	0 $0
Q4 2021 Aug 13, 2024	SELL	$34.35 - $46.38 $3,435 - $4,638	-100 Closed	0 $0
Q1 2021 Aug 13, 2024	BUY	$18.57 - $25.68 $1,857 - $2,568	100 New	100 $2.33 Million
Q4 2019 Aug 13, 2024	SELL	$7.95 - $11.84 $993 - $1,480	-125 Closed	0 $0
Q1 2019 Aug 13, 2024	BUY	$5.95 - $10.19 $743 - $1,273	125 New	125 $1.01 Million
Q1 2018 Aug 14, 2024	BUY	$7.2 - $10.05 $900 - $1,256	125 New	125 $900,000
Q3 2017 Aug 13, 2024	BUY	$12.0 - $15.0 $1,500 - $1,875	125	125 $1.81 Million

403

126M

3.27M

2.01M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.26B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.